NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 52 filers reported holding NEOS THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $651,000 | -65.4% | 950,311 | -62.1% | 0.06% | -74.0% |
| Q1 2020 | $1,882,000 | -64.7% | 2,509,468 | -28.9% | 0.24% | -46.5% |
| Q4 2019 | $5,331,000 | -7.8% | 3,530,731 | -9.7% | 0.44% | -50.9% |
| Q3 2019 | $5,784,000 | +20.8% | 3,908,265 | +5.3% | 0.89% | +36.5% |
| Q2 2019 | $4,788,000 | -16.7% | 3,711,454 | +68.6% | 0.66% | +25.0% |
| Q1 2019 | $5,746,000 | +58.2% | 2,201,697 | 0.0% | 0.52% | +28.1% |
| Q4 2018 | $3,633,000 | -9.9% | 2,201,697 | +164.7% | 0.41% | -11.7% |
| Q3 2018 | $4,034,000 | +83.3% | 831,697 | +136.2% | 0.46% | +52.8% |
| Q2 2018 | $2,201,000 | -17.3% | 352,142 | +9.8% | 0.30% | -25.0% |
| Q1 2018 | $2,662,000 | +53.5% | 320,692 | +88.6% | 0.40% | +99.0% |
| Q4 2017 | $1,734,000 | – | 170,032 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|